search

Active clinical trials for "Coronary Artery Disease"

Results 3591-3600 of 4926

Orsiro™ Drug Eluting Stent in Routine Clinical Practice

AngioplastyTransluminal2 more

The purpose of this study is to evaluate effectiveness and safety of Orsiro™ Drug Eluting Stent in Routine Clinical Practice

Completed6 enrollment criteria

Cardiovascular Oscillations in Coronary Patients With and Without Type 2 Diabetes

Coronary Artery DiseaseDiabetes Mellitus1 more

Coronary artery disease (CAD) and diabetes mellitus (DM) may promote alterations in heart responses during exercise or postural maneuver. Thus, the purpose of this study is to observe the influence of different postures (supine, seated and standing) and different percentages (15, 30, 45 and 60%) of the maximum voluntary contraction (MVC) of handgrip in the responses of heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), cardiac output (CO), stroke volume (SV) and peripheral vascular resistance (PVR) in coronary patients with and without type 2 diabetes.

Completed10 enrollment criteria

The Effect on Fluid Balance After Cardiac Surgery After Use of Two Different Priming Protocols

Coronary Heart Disease

"The impact on fluid loading after cardiac surgery by use of two different priming solution" Fluid overloading with oedema formation is a regular finding following on-pump cardiac surgery and may contribute to postoperative organ dysfunction. Myocardial oedema has been reported to impair both systolic and diastolic function. An association between intraoperative fluid loading and postoperative adverse outcome has been demonstrated in cardiac patients. The investigators have experience with the use of both colloides and combination fluids (hypertonic saline/colloides) in several experimental studies (pigs). In one animal study the investigators used colloides as an additive to the CPB-prime. The investigators observed reduced fluid leakage and less total tissue water in several organs. The planned study includes patients scheduled for coronary artery bypass, and who have no co-morbidity. The patients will be randomized to receive either Tetraspan® (HES) or acetated Ringer's solution in the CPB-prime. Accurate accounts of fluid additions, blood loss and diuresis will be kept. Determination of cardiac output (C.O.), intrathoracic blood volume (ITBV), extravascular lung water (EVLW) and global end diastolic volume (GEDV) will be monitored by use of the transpulmonary thermodilution technique PiCCO®plus system.

Completed5 enrollment criteria

Comparison of Hyperemic Efficacy Between Nicorandil and Adenosine for Fractional Flow Reserve (FFR)...

Coronary Artery DiseaseMyocardial Ischemia

The purpose of this study is to evaluate the efficacy of nicorandil in the achievement of maximal coronary hyperemia compared with adenosine.

Unknown status8 enrollment criteria

Evaluation of Effectiveness and Safety of the GENOUS STENT (IRIS-GENOUS STEMI)

Coronary Artery Disease

The objective of this study is to evaluate effectiveness and safety of GENOUS EPC-coated stent in patients with STEMI with other drug-eluting stents (DESs).

Completed5 enrollment criteria

Evaluation of Effectiveness and Safety of XIENCE PRIME Stent (IRIS-PRIME)

Coronary Artery Disease

The objective of this study is to evaluate effectiveness and safety of XIENCE PRIME stent in the "real world" daily practice as compared with other drug eluting stents (DESs)

Completed5 enrollment criteria

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

AnginaCoronary Occlusion3 more

The objectives of the PMS are to observe the frequency, type, and degree of device deficiency to assure the safety of the new medical device (XIENCE PRIME) as well as to collect information on evaluation of the efficacy and safety for reevaluation.

Completed3 enrollment criteria

BIOFLOW-III Belgium Satellite Registry

Coronary Artery DiseaseMyocardial Ischemia

This registry is a clinical post-market evaluation of the Orsiro LESS in subjects requiring coronary revascularization with Drug Eluting Stents (DES).

Completed9 enrollment criteria

Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY

Coronary Artery DiseaseCoronary Arteriosclerosis

To demonstrate the incremental utility of SSF for individuals undergoing CCTA, with expected improvements in image quality and diagnostic accuracy.

Completed17 enrollment criteria

Drug Eluting Pantera Lux Catheter Registry

Coronary Artery Disease

All comers registry - Evaluation of the safety and efficacy of the Pantera Lux Paclitaxel releasing balloon for coronary arteries in daily clinical practice.

Completed7 enrollment criteria
1...359360361...493

Need Help? Contact our team!


We'll reach out to this number within 24 hrs